🇺🇸 FDA
Patent

US 10351597

Peptide with anti-obesity and anti-diabetes activity and use thereof

granted A61KA61K38/00A61K38/08

Quick answer

US patent 10351597 (Peptide with anti-obesity and anti-diabetes activity and use thereof) held by CAREGEN CO., LTD. expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/2264, A61K38/30